An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

M. Agulnik*, J. L. Yarber, S. H. Okuno, M. von Mehren, B. D. Jovanovic, B. E. Brockstein, A. M. Evens, R. S. Benjamin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

210 Scopus citations

Fingerprint Dive into the research topics of 'An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas'. Together they form a unique fingerprint.

Medicine & Life Sciences